Administration

US shares COVID-19 technology, research with WHO to expand vaccine access

Getty Images

The White House on Thursday announced it is licensing COVID-19 technologies to the World Health Organization to enable global manufacturers to make COVID-19 shots and increase testing capability.

Through the National Institute of Health (NIH), the White House said it licensed “research tools and the intellectual property” for several COVID-19 technologies to the Medicines Patent Pool (MPP), a U.N.-backed initiative that seeks to bring medical innovations to low and middle-income countries.

These technologies include the stabilized spike protein used in many coronavirus vaccines. The spike protein is found on the surface of the COVID-19 virus. When administered, the spike protein induces an immune response that teaches the immune system to fend off an actual infection.

In his remarks at the second Global COVID-19 Summit on Thursday, President Biden touched on the technology sharing as part of “significant new commitments to help keep up the fight against COVID-19 in 2022, protect the most vulnerable populations and prepare for the next health crisis.”

The WHO said in a statement that 11 technologies from the U.S. were being licensed as part of this agreement. Apart from the spike protein, also included were diagnostic technologies, early stage COVID-19 vaccine candidates and research tools.

“I welcome the generous contribution NIH has made to C-TAP and its example of solidarity and sharing,” WHO director-general Tedros Adhanom Ghebreyesus said.

“Whether it’s today’s pandemic or tomorrow’s health emergency, it’s through sharing and empowering lower-income countries to manufacture their own health tools that we can ensure a healthier future for everyone,” he added.

Tags Biden COVID-19 testing COVID-19 vaccines Joe Biden NIH Tedros Adhanom Ghebreyesus White House COVID-19 response WHO

The Hill has removed its comment section, as there are many other forums for readers to participate in the conversation. We invite you to join the discussion on Facebook and Twitter.

Most Popular

Load more

Video

See all Video